Quantum Private Wealth’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Buy
849,212
+29,497
+4% +$137K 1.17% 15
2025
Q4
$4.51M Sell
819,715
-2,361
-0.3% -$11.5K 1.32% 13
2025
Q3
$2.69M Buy
822,076
+6,100
+0.7% +$17.3K 0.79% 25
2025
Q2
$1.88M Buy
815,976
+24,500
+3% +$53.2K 0.61% 32
2025
Q1
$1.1M Sell
791,476
-3,500
-0.4% -$5.85K 0.42% 49
2024
Q4
$1.38M Buy
794,976
+27,360
+4% +$56.8K 0.44% 42
2024
Q3
$1.54M Buy
767,616
+37,096
+5% +$81.4K 0.52% 38
2024
Q2
$1.64M Buy
730,520
+32,000
+5% +$93.1K 0.58% 34
2024
Q1
$2M Buy
698,520
+59,000
+9% +$123K 0.74% 25
2023
Q4
$1.13M Buy
639,520
+64,140
+11% +$128K 0.47% 50
2023
Q3
$1.82M Buy
575,380
+71,000
+14% +$133K 0.87% 22
2023
Q2
$333K Buy
504,380
+145,013
+40% +$105K 0.15% 132
2023
Q1
$287K Buy
359,367
+45,910
+15% +$59.3K 0.16% 138
2022
Q4
$708K Buy
313,457
+84,388
+37% +$171K 0.45% 58
2022
Q3
$442K Buy
229,069
+71,295
+45% +$259K 0.28% 93
2022
Q2
$586K Buy
157,774
+5,800
+4% +$23K 0.35% 65
2022
Q1
$990K Buy
151,974
+6,256
+4% +$46.8K 0.43% 46
2021
Q4
$1.7M Buy
+145,718
New +$2.2M 0.64% 30

Other funds holding TSHA